Radiation Oncology

Radiation oncology is a medical specialty that uses radiation therapy to treat cancer. The radiation therapy channel covers all aspects of radiation oncology technology. Radiation therapy includes linear accelerators (LINAC), proton therapy, brachytherapy, image guided radiation therapy (IGRT), focused ultrasound, stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), treatment planning systems and tomotherapy.

Adaptiiv is pioneering new approaches to bring personalization at scale to patients all over the world and is collaborating with HP and Varian to advance these efforts and meet evolving customer needs
News | Medical 3-D Printing
Adaptiiv Collaborates with HP and Varian to Enhance Personalization in Radiation Oncology

May 11, 2022 — Adaptiiv Medical Technologies is collaborating with HP Inc. and Varian, a Siemens Healthineers company ...

Time May 11, 2022
arrow
GE Healthcare is proud to announce that it has entered into an agreement to collaborate with RaySearch Laboratories AB, a leading radiation oncology software provider, to develop a new radiation therapy simulation and treatment planning workflow solution, designed to simplify how radiation will be targeted to shrink a tumor.
News | Treatment Planning
GE Healthcare Collaborates with RaySearch to Improve Radiation Oncology Treatment Planning

May 10, 2022 — GE Healthcare is proud to announce that it has entered into an agreement to collaborate with RaySearch ...

Time May 10, 2022
arrow
Update to 2012 guideline addresses advanced radiation therapy techniques and outlines best practices for patient-centered, multidisciplinary care
News | Radiation Therapy
ASTRO Issues Clinical Guideline on Radiation Therapy for Brain Metastases

May 10, 2022 — A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides guidance on ...

Time May 10, 2022
arrow
Accuray Incorporated announced that its ClearRT helical fan-beam kVCT imaging capability for the Radixact System has been selected as the winner of the “Best New Technology Solution for Oncology” award in the sixth annual MedTech Breakthrough Awards program
News | Radiation Therapy
Accuray ClearRT Helical Fan-Beam kVCT Imaging Wins “Best New Technology Solution for Oncology” MedTech Breakthrough Award

May 6, 2022 — Accuray Incorporated announced that its ClearRT helical fan-beam kVCT imaging capability for the Radixact ...

Time May 06, 2022
arrow
IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces it has received an order from CGN Medical Technologies for a Proteus PLUS[1] proton therapy system to be installed in Yangzhou, China
News | Proton Therapy
IBA Receives Order from CGNNT for a Proteus PLUS System to be Installed in Yangzhou, China

May 5, 2022 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology and the ...

Time May 05, 2022
arrow
RaySearch Laboratories AB will be showcasing the latest oncology software innovations at ESTRO 2022
News | Radiation Oncology
Latest innovations from RayStation, RayIntelligence and RayCare to be presented at ESTRO 2022

May 5, 2022 — RaySearch Laboratories AB will be showcasing the latest oncology software innovations at ESTRO 2022, to be ...

Time May 05, 2022
arrow
RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy (BgRT) for all stages of cancer, announced the enrollment of the first patient into its PREMIER registry, a prospective, real-world evidence clinical outcomes registry for patients with all stages of cancer, at the University of Texas (UT) Southwestern in Dallas.
News | Radiation Therapy
RefleXion Announces Real-World Evidence Outcomes Registry to Evaluate Treatment Impact on all Stages of Cancer

May 4, 2022 — RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy (BgRT) ...

Time May 04, 2022
arrow
IBA (Ion Beam Applications S.A.), a leader in particle accelerator technology and the leader in dosimetry quality assurance solutions, today announces it has acquired Modus Medical Devices Inc. (Modus QA), a Canadian company based in London, Ontario, specialized in phantoms for quality assurance for radiation therapy.
News | Radiology Business
IBA Strengthens its Dosimetry Portfolio with Acquisition of Modus Medical Devices Inc.

May 3, 2022 — IBA (Ion Beam Applications S.A.), a leader in particle accelerator technology and the leader in dosimetry ...

Time May 03, 2022
arrow
Sun Nuclear Corporation, a wholly-owned subsidiary of Mirion Technologies, Inc., today announced the release of the SunSCAN 3D cylindrical water scanning system for linear accelerator (linac) commissioning, beam scanning and annual Quality Assurance (QA) in Radiation Therapy.
News | Quality Assurance (QA)
Sun Nuclear Introduces SunSCAN 3D, Next-Generation Cylindrical Water Scanning System

May 3, 2022 — Sun Nuclear Corporation, a wholly-owned subsidiary of Mirion Technologies, Inc., today announced the ...

Time May 03, 2022
arrow
A schematic of the 99Mo/99mTc production system based on an electron linear accelerator and activated carbon-based 99mTc generator. Image courtesy of The University of Tokyo
Feature | Radiology Business | By Melinda Taschetta-Millane
Top 10: What Viewers Were Reading in April 2022

Here is what you and your colleagues found to be most interesting in the field of medical imaging during the month of ...

Time May 02, 2022
arrow
Lumea, a global leader in integrated digital pathology solutions and Verily, an Alphabet precision health company, announced a strategic development partnership.
News | Digital Pathology
Verily and Lumea Announce Development Partnership

April 27, 2022 — Lumea, a global leader in integrated digital pathology solutions and Verily, an Alphabet precision ...

Time April 27, 2022
arrow
66-Year-Old Man With Locally Advanced Pancreatic Cancer Undergoing Chemotherapy
News | Computed Tomography (CT)
Positive Oral CT Contrast Improves Detection of Malignant Deposits in Intra-abdominal Nonsolid Organs

April 27, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), the selection of oral contrast agent and ...

Time April 27, 2022
arrow
A group of CNIO researchers headed by Manuel Valiente have found a new strategy that could be used in patients with brain metastasis to detect radioresistance.
News | Radiation Therapy
CNIO Researchers Find a Way to Increase Effectiveness of Radiotherapy for Brain Metastasis

April 26, 2022 — A group of CNIO researchers headed by Manuel Valiente have found a new strategy that could be used in ...

Time April 26, 2022
arrow
Over the past 15 years, public health authorities have downgraded recommendations for the prostate-specific antigen (PSA) test as a screening tool to reduce the overdiagnosis and overtreatment of men with low-grade prostate cancer.
News | Prostate Cancer
Less Prostate Cancer Screening Reduces Overdiagnosis but May Miss Aggressive Cases

April 25, 2022 — Over the past 15 years, public health authorities have downgraded recommendations for the prostate ...

Time April 25, 2022
arrow
Blue Earth Therapeutics, a Bracco company and emerging leader in the development of innovative next generation therapeutic radiopharmaceuticals, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug Application (IND) application for 177Lu-rhPSMA-10.1.
News | Prostate Cancer
Blue Earth Therapeutics Announces U.S. FDA Clearance for Investigational New Drug (IND) Application for 177Lu-rhPSMA-10.1

April 19, 2022 — Blue Earth Therapeutics, a Bracco company and emerging leader in the development of innovative next ...

Time April 19, 2022
arrow
Illustration of Quantitative Analyses of CT Images.
News | Computed Tomography (CT)
Noncancerous Chest CT Features for Predicting Survival in Stage I Lung Cancer

April 15, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), noncancerous imaging markers on chest CT ...

Time April 15, 2022
arrow
Prof. Dr. Samer Ezziddin, image courtesy of Thorsten Mohr/Saarland University
News | Prostate Cancer
New Radiotracer Yields Huge Increase in Accuracy of Localizing Prostate Cancer relapses

April 15, 2022 — Prostate cancer is the most common malignant tumor in men in Germany, with about 62,000 new cases ...

Time April 14, 2022
arrow
Quantitative analysis of pre-treatment PSMA PET/CT in a patient undergoing treatment with ¹⁷⁷Lutetium-PSMA-617/NOX66. Post-treatment PSMA PET/CT demonstrates reduced tumor volume and PSMA intensity. Images created by S Pathmanandavel and L Emmett, St Vincent's Hospital, Sydney, Australia.
News | PET-CT
New Radionuclide Combination Therapy Safe and Effective in Metastatic Prostate Cancer Patients

April 11, 2022 — A novel nuclear medicine combination therapy has been proven safe and effective in men with heavily pre ...

Time April 11, 2022
arrow
Radiation to the heart during treatment for locally advanced lung cancer is associated with an increased risk of major adverse cardiac events within the first two years following treatment. The higher the cardiac dose exposure, the higher the risk of a cardiac event.
News | Lung Imaging
Simple Changes in Care Reduced Heart Exposure During Lung Cancer Radiation Treatment

April 11, 2022 — Radiation to the heart during treatment for locally advanced lung cancer is associated with an ...

Time April 11, 2022
arrow
RSIP Vision, an experienced leader in driving innovation for medical imaging through advanced artificial intelligence (AI) and computer vision solutions, announced a new tool for prostate MRI analysis.
News | Prostate Cancer
New AI Tool for Prostate MRI Analysis to Support PI-RADS Scoring

April 11, 2022 — RSIP Vision, an experienced leader in driving innovation for medical imaging through advanced ...

Time April 11, 2022
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now